Symposium of AMED SCARDA Japan Initiative for World-leading Vaccine Research and Development Centers

*Hotaka Kobayashi^1,2 (1. IQB, The University of Tokyo (Japan), 2. IAMS, Tokushima University (Japan))

*Yukari Itakura¹, Takashi Namba², Naoki Akimoto³, Kazuyuki Mekada⁴, Koshiro Tabata¹, Shinji Saito¹, Gabriel Gonzalez¹, Osamu Ichii², Hirofumi Sawa^1,3 (1. Institute for Vaccine Research and Development (IVReD), Hokkaido University (Japan), 2. Faculty of Veterinary Medicine, Hokkaido University (Japan), 3. International Institute for Zoonosis Control, Hokkaido University (Japan), 4. Department of Zoology, Okayama University of Science (Japan))

*Koto Hattori¹, Yuhei Nogami¹, Yohei Uchida¹, Hiroshi Kiyono^1,2,3,4,5, Rika Nakahashi^1,2 (1. Department of Human Mucosal Vaccinology, Chiba University Hospital (Japan), 2. Synergy Institute for Futuristic Mucosal Vaccine Research and Development (cSIMVa), Chiba University (Japan), 3. Future Medicine Education and Research Organization, Chiba University (Japan), 4. Department of Medicine, UC San Diego School of Medicine (USA), 5. CU-UCSD Center for Mucosal Immunology, Allergy and Vaccines (cMAV), UC San Diego School of Medicine (USA))

*Huai Chuang^1,2, Agnieszka Gromadka³, Shara Bakytbek^1,4, Wataru Kagaya^1,5, Vegard Børve Sørdal³, Marius Gheorghe³, Shusaku Mizukami^1,6, Shinya Miyazaki^1,2, Yarob Ibraheem^1,4, Farzaneh Valanezhad^1,4, Ayako Hyuga^1,4, Shin-Ichi Inoue^1,7, Satoshi Kaneko^1,5, Sebastian Kapell^1,8, Ioannis Vardaxis³, Alexandru Odainic³, Matheus Ferraz³, Kazuhide Onoguchi⁹, Daiki Mori⁹, Daiki Miura⁹, Shinjiro Hamano^1,4, Kaïdre Bendjama³, Osamu Kaneko^1,2 (1. VRDC, DEJIMA Infectious Disease Research Alliance, Nagasaki Univ. (Japan), 2. Dept. Protozool., Inst. Trop. Med. (NEKKEN), Nagasaki Univ. (Japan), 3. NEC Oncoimmunity AS, Oslo (Norway), 4. Dept. Parasitol., Inst. Trop. Med. (NEKKEN), Nagasaki Univ. (Japan), 5. Dept. Eco-epidemiol., Inst. Trop. Med. (NEKKEN), Nagasaki Univ. (Japan), 6. Dept. Immun. Regul., Inst. Trop. Med. (NEKKEN), Nagasaki Univ. (Japan), 7. Dept. Immunol., Grad. Sch. Biomed. Sci., Nagasaki Univ. (Japan), 8. Dept. Vacc. Inform., Inst. Trop. Med. (NEKKEN), Nagasaki Univ. (Japan), 9. NEC Corporation (Japan))

*Taiki Ito^1,2,3, Kota Senpuku^2,4, Mika Hirose⁵, Tatsuya Karaki^2,6, Yuta Kunishima^2,6, Kotaro Taniguchi^2,4, Toshiro Hirai^1,2,3,4, Takayuki Kato^1,5, Yasuo Yoshioka^1,2,3,4,6 (1. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 2. Research Institute for Microbial Diseases, The University of Osaka (Japan), 3. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan), 4. Graduate School of Pharmaceutical Sciences, The University of Osaka (Japan), 5. Institute for protein research, The University of Osaka (Japan), 6. The Research Foundation for Microbial Diseases of Osaka University (Japan))

*Go Sato^1,2,3, Ryuya Edahiro^2,3, Tomohiro Yata², Yuji Yamamoto², Kotaro Ogawa², Ryunosuke Saiki⁴, Kyuto Sonehara^1,2,3, Yuya Shirai^2,3, Shinichi Namba^1,2,3, Ho Namkoong⁵, Atsushi Kumanogoh², Seishi Ogawa⁴, Noriko Isobe⁶, Tatsusada Okuno², Koichi Matsuda⁷, Toshimasa Yamauchi¹, Takashi Kadowaki⁸, Yukinori Okada^1,2,3 (1. Graduate School of Medicine, the University of Tokyo (Japan), 2. Graduate School of Medicine, the University of Osaka (Japan), 3. RIKEN Center for Integrative Medical Sciences (Japan), 4. Graduate School of Medicine, Kyoto University (Japan), 5. Keio University School of Medicine (Japan), 6. Graduate School of Medical Sciences, Kyusyu University (Japan), 7. Graduate School of Frontier Sciences, the University of Tokyo (Japan), 8. Toranomon Hospital (Japan))

*Khanui Lkhagvadorj¹, Eiichi Okamura¹, Yasushi Itoh², Seiya Mizuno³, Knut Woltjen⁴, Masatsugu Ema^1,5 (1. Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga University of Medical Science (Japan), 2. Division of Pathogenesis and Disease Regulation, Department of Pathology, Shiga University of Medical Science (Japan), 3. Laboratory Animal Resource Center in Trans-border Medical Research Center, University of Tsukuba (Japan), 4. Department of Life Science Frontiers, Center for iPS Cell Research and Application (CiRA), Kyoto University (Japan), 5. Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University (Japan))

*Natsuko Yamakawa¹, Yasuhiro Yasutomi¹ (1. NIBN (Japan))

*Kaori Sano^1,2, Hideaki Kato^3,4, Akihide Ryo^5,6, Hideki Hasegawa^1,2, Kei Miyakawa^1,2,6 (1. Institute for Vaccine Research and Development, Hokkaido University (Japan), 2. Influenza Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 3. Emerging Infectious Diseases Research Center, Advanced Medical Research Center, Yokohama City University (Japan), 4. Infection Prevention and Control Department, Yokohama City University Hospital (Japan), 5. Department of Bioinformatics and Integrative Omics, National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 6. Department of Microbiology, Yokohama City University School of Medicine (Japan))